BACKGROUND: In 2006, Australia introduced new publicly funded psychological services for people with affective and anxiety disorders (the Better Access programme). Despite massive uptake, it has been suggested that Better Access is selectively treating socioeconomically advantaged people, including some who do not warrant treatment, and people already receiving equivalent services. AIMS: To explore potential disparities in Better Access treatment using epidemiological data from the 2007 National Survey of Mental Health and Wellbeing. METHOD: Logistic regression analyses examined patterns and correlates of service use in two populations: people who used the new psychological services in the previous 12 months; and people with any ICD-10 12-month affective and anxiety disorder, regardless of service use. RESULTS: Most (93.2%) Better Access psychological services users had a 12-month ICD-10 mental disorder or another indicator of treatment need. Better Access users without affective or anxiety disorders were not more socioeconomically advantaged, and received less treatment than those with these disorders. Among the population with affective or anxiety disorders, non-service users were less likely to have a severe disorder and more likely to have anxiety disorder, without a comorbid affective disorder, than Better Access users. Better Access users comprised more new allied healthcare recipients than other service users. A substantial minority of non-service users (13.5%) had severe disorders, but most did not perceive a need for treatment. CONCLUSIONS: Better Access does not appear to be overservicing individuals without potential need or contributing to social inequalities in mental healthcare. It appears to be reaching people who have not previously received psychological care. Treatment rates could be improved for some people with anxiety disorders.
BACKGROUND: In 2006, Australia introduced new publicly funded psychological services for people with affective and anxiety disorders (the Better Access programme). Despite massive uptake, it has been suggested that Better Access is selectively treating socioeconomically advantaged people, including some who do not warrant treatment, and people already receiving equivalent services. AIMS: To explore potential disparities in Better Access treatment using epidemiological data from the 2007 National Survey of Mental Health and Wellbeing. METHOD: Logistic regression analyses examined patterns and correlates of service use in two populations: people who used the new psychological services in the previous 12 months; and people with any ICD-10 12-month affective and anxiety disorder, regardless of service use. RESULTS: Most (93.2%) Better Access psychological services users had a 12-month ICD-10 mental disorder or another indicator of treatment need. Better Access users without affective or anxiety disorders were not more socioeconomically advantaged, and received less treatment than those with these disorders. Among the population with affective or anxiety disorders, non-service users were less likely to have a severe disorder and more likely to have anxiety disorder, without a comorbid affective disorder, than Better Access users. Better Access users comprised more new allied healthcare recipients than other service users. A substantial minority of non-service users (13.5%) had severe disorders, but most did not perceive a need for treatment. CONCLUSIONS: Better Access does not appear to be overservicing individuals without potential need or contributing to social inequalities in mental healthcare. It appears to be reaching people who have not previously received psychological care. Treatment rates could be improved for some people with anxiety disorders.
Authors: Cecily McIntyre; Meredith G Harris; Amanda J Baxter; Stuart Leske; Sandra Diminic; Joseph P Gone; Ernest Hunter; Harvey Whiteford Journal: Health Res Policy Syst Date: 2017-08-04
Authors: Joanne C Enticott; Frances Shawyer; Lisa Mary Brophy; Grant Russell; Danielle Mazza; Elisabeth Wilson-Evered; Penelope June Weller; Mike Slade; Vrinda Edan; Graham Nicholas Meadows Journal: Front Psychiatry Date: 2021-03-11 Impact factor: 4.157
Authors: Shelley Rhodes; David A Richards; David Ekers; Dean McMillan; Sarah Byford; Paul A Farrand; Simon Gilbody; Steven D Hollon; Willem Kuyken; Christopher Martell; Heather A O'Mahen; Emer O'Neill; Nigel Reed; Rod S Taylor; Ed R Watkins; Kim A Wright Journal: Trials Date: 2014-01-21 Impact factor: 2.279
Authors: Richard Taylor; Andrew Page; Alex Wodak; Michael Dudley; Sonali Munot; Stephen Morrell Journal: BMC Public Health Date: 2018-08-03 Impact factor: 3.295